Garland Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prudential Financial
PRU
|
+$99.3K |
| 2 |
CVS Health
CVS
|
+$61.8K |
| 3 |
3M
MMM
|
+$51K |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$40.3K |
| 5 |
JPMorgan Chase
JPM
|
+$27.9K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Travelers Companies
TRV
|
+$3.69M |
| 2 |
TotalEnergies
TTE
|
+$1.97M |
| 3 |
Pfizer
PFE
|
+$263K |
| 4 |
ExxonMobil
XOM
|
+$20.6K |
| 5 |
Novartis
NVS
|
+$17.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.28% |
| 2 | Industrials | 18% |
| 3 | Financials | 15.34% |
| 4 | Real Estate | 13.22% |
| 5 | Consumer Staples | 10.06% |
Similar funds
Garland Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Garland Capital Management held 30 positions worth $118M, up 5.3% from $112M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Garland Capital Management withdrew a net $5.46M in Q4 2020, closing 2 positions and reducing 3 holdings. Its most notable exit was Travelers Companies, an estimated $3.69M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 27% a quarter earlier, followed by Industrials and Financials.
Against the trend, Garland Capital Management added an estimated $99.3K to Prudential Financial.
- Garland Capital Management added most to Prudential Financial in Q4 2020, an estimated $99.3K increase.
- Garland Capital Management's biggest Q4 2020 reduction was Pfizer, cutting an estimated $263K.
- Garland Capital Management fully exited Travelers Companies in Q4 2020, selling an estimated $3.69M.
- Garland Capital Management's ten largest holdings make up 52% of its $118M portfolio in Q4 2020.
- Garland Capital Management opened 0 new positions and closed 2 in Q4 2020.
- Garland Capital Management's portfolio value rose 5.3% quarter-over-quarter to $118M.
Based on Garland Capital Management's 13F filing for Q4 2020, filed 9 Feb 2021.